Ipca Laboratories (BOM:524494) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524494 Ipca Laboratories Ltd BOM:524494
93 GF Score
Price ₹1,798.80
GF Value ₹1,599.93
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ipca Laboratories Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BOM:524494
93GF Score
Ipca Laboratories Ltd BOM:524494
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipca Laboratories (BOM:524494) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,798.80 is trading 12.4% above its estimated GF Value™ of ₹1,599.93. GuruFocus considers Ipca Laboratories to be Modestly Overvalued.

Key valuation signals for BOM:524494:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹1,599.93 vs. price of ₹1,798.80 (12.4% above fair value)
  • GF Score™: 93/100 with 6 warning signs

No single metric tells the full story. See the BOM:524494 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipca Laboratories Business Description

Other Exchanges IPCALAB:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
93GF Score

Get the complete analysis for BOM:524494

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,798.80
Price
₹1,599.93
GF Value